Rx IP Update - August 2018

Published date04 September 2018
Law FirmSmart & Biggar
AuthorNancy Pei,Abigail Smith,Urszula Wojtyra,Katie Lee,Brandon Heard,Andrew Mandlsohn
Subject MatterData Protection,Patents,Appeals,Obviousness,Motion to Dismiss,Eli Lilly,Premarket Approval Applications,Public Comment,Patent Litigation,Pharmaceutical Patents,Canada,Patent Infringement,Teva Pharmaceuticals,Apotex,Drug Pricing,Pharmaceutical Industry,Health Canada,CADTH,PMNOC Regulations,Patented Medicine Prices Review Board (PMPRB)

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT